Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Next 150 Index | N150 | Dec 24, 2024 | 3 238.97 | +0.21 |
Nextedia | ALNXT | Dec 24, 2024 | 0.43 | -0.70 |
NFL Biosciences S.A. | ALNFL | Dec 24, 2024 | 1.80 | -0.33 |
NHOA | NHOA | Dec 24, 2024 | 1.24 | 0.00 |
Nicolas Miguet and Associes S.A | MLNMA | Dec 24, 2024 | 0.08 | 0.00 |
Nicox SA | ALCOX | Dec 24, 2024 | 0.28 | -2.41 |
Nokia | NOKIA | Dec 24, 2024 | 4.25 | +0.35 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NBA | Dec 24, 2024 | 5.85 | 0.00 |
Novacyt | ALNOV | Dec 24, 2024 | 0.59 | -0.51 |
Novatech Industries | MLNOV | Dec 24, 2024 | 10.50 | 0.00 |
NR 21 | NR21 | Dec 24, 2024 | 35.20 | 0.00 |
NRJ Group | NRG | Dec 24, 2024 | 7.00 | +0.57 |
NSC Groupe | ALNSC | Dec 24, 2024 | 60.00 | -6.98 |
NSE SA | ALNSE | Dec 24, 2024 | 28.70 | +0.70 |
Obiz | ALBIZ | Dec 24, 2024 | 4.79 | +0.21 |
Odyssee Technologies S.A. | ALODY | Dec 24, 2024 | 14.50 | 0.00 |
Oeneo | SBT | Dec 24, 2024 | 9.80 | 0.00 |
Omer-Decugis & Cie | ALODC | Dec 24, 2024 | 4.11 | -0.24 |
Oncodesign Precision Medicine S.A | ALOPM | Dec 24, 2024 | 0.76 | -2.56 |
One Experience | ALEXP | Dec 24, 2024 | 0.31 | 0.00 |
Onlineformapro | MLONL | Dec 24, 2024 | 1.80 | +5.88 |
OPmobility | OPM | Dec 24, 2024 | 9.79 | +0.77 |
Orange. | ORA | Dec 24, 2024 | 9.50 | +0.27 |
Orapi | ORAP | Dec 24, 2024 | 6.50 | 0.00 |
Ordissimo | ALORD | Dec 24, 2024 | 0.69 | +1.77 |
Orege | OREGE | Dec 24, 2024 | 0.37 | +1.36 |
OSE Immunotherapeutics | OSE | Dec 24, 2024 | 7.06 | +0.71 |
Osmosun S.A | ALWTR | Dec 24, 2024 | 1.30 | -0.15 |
OVH GROUPE (PROM.)EO 1 | OVH | Dec 24, 2024 | 8.54 | +0.53 |
Pacte Novation | MLPAC | Dec 24, 2024 | 9.10 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.